Testosterone may have a role distinct from cortisol in the pathophysiology of depression. The hypothalamus-pituitary-adrenal (HPA) axis affects the functions of sex steroid hormones through interaction with corticotropin-releasing hormone (CRH) and gonadotropin-releasing hormone (GnRH). The objective of this study was to investigate differences in serum levels of testosterone and cortisol in male and female patients with major depressive disorder (MDD).
Methods:
Participants included 87 inpatients with MDD at Juntendo University Koshigaya Hospital. Serum levels of testosterone and cortisol were assessed at admission. Matched controls included 128 healthy individuals. Data from MDD patients and controls were compared separately for men and women. Correlations between serum hormone levels and scores on the Hamilton Rating Scale for Depression (HAM-D) of patients were assessed by sex. Effects of various factors on testosterone and cortisol were analyzed using multiple regression analysis.
Results:
In male patients with MDD, a significant negative correlation was seen between testosterone levels and the “retardation” score of HAM-D. However, serum testosterone levels were not significantly different in either male or female MDD patients compared with controls. Serum testosterone was negatively associated with the number of depressive episodes in male patients with MDD. Serum cortisol levels in female patients were significantly increased compared with female controls with no significant correlations between cortisol levels and HAM-D scores.
Conclusions:
The negative correlation between the sub-score of the HAM-D and testosterone may be associated with the biological pathophysiology of male depression. Findings of serum cortisol levels in women may suggest distinct characteristics of these hormones in men and women with MDD.
MoncadaI. Testosterone and men's quality of life. The Aging Male2006; 9: 189–193.
2.
SpivakBMaayanRMesterRWeizmanA. Plasma restosterone levels in patients with combat-related posttraumatic stress disorder. Neuropsychobiology2003; 47: 57–60.
3.
ZarroufFAArtzSGriffithJSirbuCKommorM. Testosterone and depression. Systematic review and meta-analysis. Journal of Psychiatric Practice2009; 15: 289–305.
4.
SeidmanSNOrrGRavivGLeviRRooseSPKravitzEAmiazRWeiserM. Effects of testosterone replacement in middle-aged men with dysthymia. A randomized, placebo-controlled clinical trial. Journal of Clinical Psychopharmacology2009; 29: 216–221.
5.
RivierCValeW. Effect of long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat. The Journal of Clinical Investigation1985; 75: 689–694.
6.
MacLuskyNJNaftolinFLeranthC. Immunocytochemical evidence for direct synaptic connections between corticotropine-releasing factor (CRF) and gonadotropin-releasing hormone (GnRH)-containing neurons in the preoptic area of the rat. Brain Research1988; 439: 391–395.
7.
ParianteCMMillerAH. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biological Psychiatry2001; 49: 391–404.
8.
ZumoffBFukushimaDKWeitzmanEDKreamJHellmanL. The sex difference in plasma cortisol concentration in man. The Journal of Clinical Endocrinology and Metabolism1974; 39: 805–808.
9.
van CauterELeproultRKupferDJ. Effects of gender and age on the levels and circadian rhythmicity of plasma cortisol. The Journal of Clinical Endocrinology and Metabolism1996; 81: 2468–2473.
10.
KirschbaumCWustSHelhammerD. Consistent sex differences in cortisol responses to psychological stress. Psychosomatic Medicine1992; 54: 648–657.
11.
InagakiAInabaT. Dose equivalence of psychotropic drugs. Part X VIII dose equivalence of psychotropic drugs: 2006-Version. Japanese Journal of Clinical Psychopharmacology2006; 9: 1443–1447.
12.
FeighnerJPCohnJBFabreLFJrFieveRRMendelsJShrivastavaRKDunbarGC. A study comparing paroxetine placebo and imipramine in depressed patients. Journal of Affective Disorders1993; 28: 71–79.
13.
BenazziF. Psychomotor changes in melancholic and atypical depression: 1976 unipolar and bipolar II subtypes. Psychiatry Research2002; 112: 211–220.
LevittAJJoffeRT. Total and free testosterone in depressed men. Acta Psychiatrica Scandinavica1988; 77: 346–348.
16.
KanedaYFujiiA. No relationship between testosterone levels and depressive symptoms in aging men. European Psychiatry2002; 17: 411–413.
17.
Barrett-ConnorEVon MuhlenDGKritz-SilversteinD. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo study. The Journal of Clinical Endocrinology and Metabolism1999; 84: 573–577.
18.
BellSShipmanMBystritskyAHaifleyT. Fluoxetine treatment and testosterone levels. Annals of Clinical Psychiatry2006; 18: 19–22.
19.
RubinRTPolandRELesserIM. Neuroendocrine aspects of primary endogeneous depression VIII. Pituitary-gonadal axis activity in male patients and matched control subjects. Psychoneuroendocrinology1989; 14: 217–229.
20.
DaviesRHHarrisBThomasDRCookNReadGRiad-FahmyD. Salivary testosterone levels and major depressive illness in men. The British Journal of Psychiatry1992; 161: 629–632.
21.
SchweigerUDeuschleMWeberBKornerALammerC-LSchmiderJGotthardtUHeuserI. Testosterone, gonadotropin, and cortisol secretion in male patients with major depression. Psychosomatic Medicine1999; 61: 292–296.
22.
SeidmanSNWalshBT. Testosterone and depression in aging men. American Journal of Psychiatry1999; 7: 18–33.
23.
McIntyreRSManciniDEisfeldBSSoczynskaJKGruppLKonarskiJZKennedySH. Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology2006; 31: 1029–1035.
24.
SeimanSNAraujoABRooseSPDevanandDPXieSCooperTBMcKinlayJB. Low testosterone levels in elderly men with dysthymic disorder. American Journal of Psychiatry2002; 159: 456–459.
25.
ShoresMMMoceriVMSloanKLMatsumotoAMKivlabanDR. Low testosterone levels predict incident depressive illness in older men: Effects of age and medical morbidity. Journal of Clinical Psychiatry2005; 66: 7–14.
26.
CarnahanRMPerryPJ. Depression in aging men. The role of testosterone. Drugs Aging2004; 21: 361–376.
27.
ZittzmannMNieschlagE. Testosterone levels in healthy men and the relation to behavioural and physical characteristics: Facts and constructs. European Journal of Endocrinology2001; 144: 183–197.
28.
KuritaHMaeshimaHKidaSMatsuzakaHShimanoTNakanoYBabaHSuzukiTAraiH. Serum dehydroepiandrosterone (DHEA) and DHEA-sulfate (S) levels in medicated patients with major depressive disorder compared with controls. Journal of Affective Disorders2013; 146: 205–212.
29.
BaischerWKoinigGHartmannBHuberJLangerG. Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: Elevated blood testosterone concentrations compared to normal controls. Psychoneuroendocrinology1995; 20: 553–559.
30.
WeberBLewickaSDeuschleMCollaMHeuserI. Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression. Psychoneuroendocrinology2000; 25: 765–771.
ErdinclerDBugayGErtanTEkerE. Depression and sex hormones in elderly women. Archives of Gerontology and Geriatrics2004; 39: 239–244.
33.
HolsenLMSpaethSBLeeJ-HOgdenLAKlibanskiAWhitfield-GabrieliSGoldsteinJM. Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression. Journal of Affective Disorders2011; 131: 379–387.
34.
HeuserIJGotthardtUSchweigerUSchmiderJLammersC-HDettlingMHolsboerF. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiology of Aging1994; 15: 227–231.
35.
SeemanTESingerBCharpentieP. Gender differences in patterns of HPA axis response to challenge: Macarthur studies of successful aging. Psychoneuroendocrinology1995; 20: 711–725.
36.
KunzelHEBinderEBNickelTIsingMFuchsBMajerMPfennigAErnstGKernNSchmidDAUhrMHolsboerFMedellS. Pharmacological and non-pharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology2003; 28: 2169–2178.
37.
KunugiHIdaIOwashiTKimuraMInoueYNakagawaSYabanaTUrushibaraTKanaiRAiharaMYuukiNOtsuboTOshimaAKuboKInoueTKitaichiYShirakawaOIsogawaKNagayamaHKamijimaKNankoSKanbaSHiguchiTMikuniM. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: A multicenter study. Neuropsychopharmacology2006; 31: 212–220.
38.
NickelTSonntagASchillJZobelAWAcklNBrunnauerAMurckHIsingMYassouridisASteigerAZihlJHolsboerF. Clinical and neurobiological effects of tianeptine and paroxetine in major depression. Journal of Clinical Psychopharmacology2003; 23: 155–168.
39.
SchuleCBaghaiTZwanzgerPEllaREserDPadbergFMollerHJRupprechtR. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine. Psychopharmacology2003; 166: 271–275.
40.
EgelandJLundALandroNIRundBRSundetKAsbjornsenAMjellemNRonessAStordalKI. Cortisol level predicts executive and memory function in depression, symptom level predicts psychomotor speed. Acta Psychiatrica Scandinavica2005; 112: 434–441.
41.
ReppermundSZihlJLucaeSHorstmannSKloiberSHolsboerFIsingM. Persistent cognitive impairment in depression: The role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation. Biological Psychiatry2007; 62: 400–406.
42.
TankeMACBoskerFJGladkevichAVMedemaHMden BoerJAKorfJ. Lymphocyte glucocorticoid receptor resistance and depressive symptoms severity: A preliminary report. Progress in Neuro-Psychopharmacology & Biological Psychiatry2008; 32: 1298–1301.
43.
MichopoulosIZervasIMPantelisCTsaltasEPapakostaV-MBoufidouFNikolaouCPapageoriouCSoldatosCRLykourasL. Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression. European Archives of Psychiatry and Clinical Neuroscience2008; 258: 217–225.
44.
ZobelAWNickelTSonntagAUhrMHolsboerFIsingM. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study. Journal of Psychiatric Research2001; 35: 83–94.
45.
BremmerMADeegDJHBeekmanATFPenninxBWJHLipsPHoogendijkWJG. Major depression in late life is associated with both hypo- and hypercortisolemia. Biological Psychiatry2007; 62: 479–486.
46.
WardenaarKJVreeburgSAvan VeenTGiltayEJVeenGPenninxBWJHZitmanFG. Dimensions of depression and anxiety and the hypothalamo-pituitary-adrenal axis. Biological Psychiatry2011; 69: 366–373.
47.
MantheyLLeedsCGiltayEJvan VeenTVreeburgSAPenninxBWJHZitmanFG. Antidepressant use and salivary cortisol in depressive and anxiety disorders. European Neuropsychopharmacology2011; 21: 691–699.
48.
BrambillaDJMcKinlaySMMcKinlayJBWeissSRJohannesCBCrawfordSLLongcopeC. Does collecting repeated samples from each subject improve the precision of estimated steroid hormone levels?Journal of Clinical Epidemiology1996; 49: 345–350.
49.
Emadi-KonjinPBainJBrombergIL. Evaluation of an algorithm for calculation of serum “available” testosterone (BAT). Clinical Biochemistry2003; 36: 591–596.
50.
RosnerW. An extraordinarily inaccurate assay for free testosterone is still with us. The Journal of Clinical Endocrinology and Metabolism2001; 86: 2903.
51.
ShoresMMMoceriVMGruenewaldDABrodkinKIMatsumotoAMKivlabanDR. Low testosterone is associated with decreased function and increased mortality risk: A preliminary study of men in a geriatric rehabilitation unit. Journal of the American Geriatrics Society2004; 52: 2077–2081.
52.
AlmeidaOPYeapBBHankeyGJJamrozikKFlickerL. Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. Archives of General Psychiatry2008; 65: 283–289.
